S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2′-deoxycoformycin alone and in combination with 9-β-D-arabinofuranosyladenine.

HERSHFIELD M S; KREDICH N M; KOLLER C A; MTCHELL B S; KURTZBERG J; KINNEY T R; FALLETTA J M

Art

J-GLOBAL ID：200902000083302986 Reference number：83A0420359

S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2′-deoxycoformycin alone and in combination with 9-β-D-arabinofuranosyladenine.

2′-デオキシコホルマイシン単独および9-β-dアラビノフラノシルアデニン併用によるT-細胞急性リンパ芽細胞白血病治療中におけるS-アデノシルホモシステインの異化代謝と獲得耐性の根拠

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=83A0420359&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=83A0420359&from=J-GLOBAL&jstjournalNo=D0045B") }}

Author (7)： , , , , , ,
Material：
Volume： 43 Issue： 7 Page： 3451-3458 Publication year： Jul. 1983
JST Material Number： D0045B ISSN： 0008-5472 CODEN： CNREA8 Document type： Article
Article type：原著論文 Country of issue： United States (USA) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=83A0420359&from=J-GLOBAL&jstjournalNo=D0045B") }}

Clinical application of antitumor(=antineoplastic)drugs , Clinical application of antitumor(=antineoplastic)antibiotics , Drug therapy(=pharmacotherapy)for tumors

, , , , , , , , , , , ,

Return to Previous Page